Secondary prevention in myocardial infarction patients with known coronary artery disease
Tidsskrift for Den norske legeforening · 2025
DOI: 10.4045/tidsskr.25.0186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tidsskrift for Den norske legeforening, 2025. Verfasst von Jarle Jortveit und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medisinsk avdeling, Sørlandet sykehus Arendal. Hauptthemen laut MEDLINE: Secondary Prevention, Myocardial Infarction, Coronary Artery Disease. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Secondary preventive treatment for patients with known coronary artery disease reduces the risk of new cardiovascular events. We studied the extent to which patients with known coronary artery disease who were admitted with acute myocardial infarction had achieved the treatment targets for secondary prevention. Material and method: The study used data from the Norwegian Myocardial Infarction Registry and included patients below the age of 85 years with known coronary artery disease who were admitted with type 1 myocardial infarction to Norwegian hospitals in the period from 1 January 2013 to 31 December 2022.
Results
Out of 74,993 patients below the age of 85 years who were admitted with type 1 acute myocardial infarction, 22,825 (30.4 %) had known coronary artery disease. Of these patients, 24.4 % were women and the median age was 72 years (interquartile range 64-78). The proportion with known coronary artery disease was stable during the study period. The proportion of non-smokers increased from 71 % to 75 % (+0.7 % per year), the proportion of patients with a healthy weight decreased from 33 % to 29 % (-1.8 % per year), and the proportion receiving antiplatelet and/or anticoagulant therapy increased from 88 % to 91 % (+0.3 % per year). The proportion receiving lipid-lowering therapy (77.0 %) and the proportion who had LDL cholesterol < 1.8 mmol/L (21 %) was stable. The proportion of patients with blood pressure < 140/90 mmHg decreased from 43 % to 30 % (-4.6 % per year until 2020, then unchanged).
Interpretation
The study demonstrates the need for measures to improve secondary preventive treatment in patients with coronary artery disease in Norway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medisinsk avdeling, Sørlandet sykehus Arendal.
- Medisinsk avdeling, Drammen sykehus, og, Avdeling for atferdsmedisin, Universitetet i Oslo.
- Medisinsk avdeling, Kongsvinger sykehus, og, Forskningsenheten, Sørlandet sykehus Arendal.
- Hjertemedisinsk avdeling, Oslo universitetssykehus, Ullevål, og, Institutt for klinisk medisin, Universitetet i Oslo.
ORCID-Profile: Jarle Jortveit
Zitieren
APA
Jortveit, J., Munkhaugen, J., Kaldal, A., & Halvorsen, S. (2025). Secondary prevention in myocardial infarction patients with known coronary artery disease. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.25.0186
Vancouver
Jortveit J, Munkhaugen J, Kaldal A, Halvorsen S. Secondary prevention in myocardial infarction patients with known coronary artery disease. Tidsskrift for Den norske legeforening. 2025. doi:10.4045/tidsskr.25.0186
BibTeX
@article{Jortveit2025,
author = {Jortveit, Jarle and Munkhaugen, John and Kaldal, Anete and Halvorsen, Sigrun},
title = {Secondary prevention in myocardial infarction patients with known coronary artery disease},
journal = {Tidsskrift for Den norske legeforening},
year = {2025},
doi = {10.4045/tidsskr.25.0186}
}
EUVIMED